zopolrestat and minalrestat

zopolrestat has been researched along with minalrestat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dhagat, U; El-Kabbani, O; Endo, S; Hara, A	1
El-Kabbani, O; Endo, S; Hara, A; Kitade, Y; Kuwata, K; Matsunaga, T; Zhao, HT	1

Other Studies

2 other study(ies) available for zopolrestat and minalrestat

Article	Year
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors. Bioorganic & medicinal chemistry, 2008, Mar-15, Volume: 16, Issue:6 Topics: 3-Hydroxysteroid Dehydrogenases; Aldehyde Reductase; Animals; Binding Sites; Enzyme Inhibitors; Mice; Models, Molecular; Protein Binding; Substrate Specificity	2008
Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10. Bioorganic & medicinal chemistry, 2010, Apr-01, Volume: 18, Issue:7 Topics: Aldehyde Reductase; Aldehydes; Aldo-Keto Reductases; Antineoplastic Agents; Benzopyrans; Biomarkers, Tumor; Catalytic Domain; Computer Simulation; Databases, Factual; Drug Discovery; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Farnesol; HeLa Cells; Humans; Kinetics; Models, Molecular; Protein Binding; Recombinant Proteins; Substrate Specificity	2010

Article

Year

Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.

Bioorganic & medicinal chemistry, 2008, Mar-15, Volume: 16, Issue:6

Topics: 3-Hydroxysteroid Dehydrogenases; Aldehyde Reductase; Animals; Binding Sites; Enzyme Inhibitors; Mice; Models, Molecular; Protein Binding; Substrate Specificity

2008

Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10.

Bioorganic & medicinal chemistry, 2010, Apr-01, Volume: 18, Issue:7

Topics: Aldehyde Reductase; Aldehydes; Aldo-Keto Reductases; Antineoplastic Agents; Benzopyrans; Biomarkers, Tumor; Catalytic Domain; Computer Simulation; Databases, Factual; Drug Discovery; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Farnesol; HeLa Cells; Humans; Kinetics; Models, Molecular; Protein Binding; Recombinant Proteins; Substrate Specificity

2010